Dextran 70 administration after trauma-hemorrhagic shock does not impair cellular immune functions
- 31 December 1994
- journal article
- Published by Elsevier in Journal of Critical Care
- Vol. 9 (4) , 244-254
- https://doi.org/10.1016/0883-9441(94)90004-3
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Isovolemic Hemodilution with Dextran 60 as Treatment of Pancreatic Ischemia in Acute Pancreatitis Clinical Practicability of an Experimental ConceptAnnals of Surgery, 1993
- Protective Effects of Preheparinization on the Microvasculature During and After Hemorrhagic ShockPublished by Wolters Kluwer Health ,1992
- Resuscitation fluids for the treatment of hemorrhagic shock in dogsCritical Care Medicine, 1991
- On the mechanism of dextran-induced histamine secretion from rat peritoneal mast cellsInflammation Research, 1987
- Evaluation of immunomodulatory chemicals: Alteration of macrophage function in vitroToxicology and Applied Pharmacology, 1984
- PREVENTION OF DEXTRAN-INDUCED ANAPHYLACTOID REACTIONS BY HAPTEN INHIBITIONThe Lancet, 1980
- Effect of Dextran on Factor VIII (Antihemophilic Factor) and Platelet FunctionAnnals of Surgery, 1979
- Dextrans and Fibrin MorphologyNature, 1972
- DEXTRAN‐INDUCED ANAPHYLACTOID REACTIONS IN CONNECTION WITH SURGERYActa Anaesthesiologica Scandinavica, 1970
- " REACTIONS " TO DEXTRANThe Lancet, 1953